연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
1187. Introduction of the CIITA gene into tumor cells produces exosomes with enhanced anti-tumor effects.
Lee YS, Kim SH, Cho JA, Kim CW.
Exp Mol Med. 2011 May 31;43(5):281-90. doi: 10.3858/emm.2011.43.5.029.
Link
1186. Treatment with mANT2 shRNA enhances antitumor therapeutic effects induced by MUC1 DNA vaccination.
Choi Y, Jeon YH, Jang JY, Chung JK, Kim CW.
Mol Ther. 2011 May;19(5):979-89. Epub 2010 Nov 9.
Link
1185. MicroRNA-146a downregulates NFκB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma.
Paik JH, Jang JY, Jeon YK, Kim WY, Kim TM, Heo DS, Kim CW.
Clin Cancer Res. 2011 Jul 15;17(14):4761-71. Epub 2011 May 24.
Link
1184. The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1.
Kim MK, Jeon YK, Woo JK, Choi Y, Choi DH, Kim YH, Kim CW.
Mol Cancer. 2011 Aug 16;10:98.
Link
1183. Increasing nodal ratio is a poor prognostic factor for survival in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant chemotherapy: a retrospective study.
Kim JS, Kim MA, Oh DY, Lee SH, Kim DW, Im SA, Kim WH, Yang HK, Heo DS, Bang YJ, Lee KU, Kim TY, Kim TM, Kim NK, Choe KJ.
Jpn J Clin Oncol. 2011 Feb;41(2):245-52. Epub 2010 Nov 24.
Link
1182. Discordant human epidermal growth factor receptor 2 and hormone receptor status in primary and metastatic breast cancer and response to trastuzumab.
Chang HJ, Han SW, Oh DY, Im SA, Jeon YK, Park IA, Han W, Noh DY, Bang YJ, Kim TY.
Jpn J Clin Oncol. 2011 May;41(5):593-9. Epub 2011 Mar 15.
Link
1181. Aurintricarboxylic acid inhibits the nuclear factor-κB-dependent expression of intercellular cell adhesion molecule-1 and endothelial cell selectin on activated human endothelial cells.
Kim JE, Lee S, Han KS, Kim HK.
Blood Coagul Fibrinolysis. 2011 Mar;22(2):132-9.
Link
1180. Neutrophil and monocyte activation markers have prognostic impact in disseminated intravascular coagulation: in vitro effect of thrombin on monocyte CD163 shedding.
Chung S, Kim JE, Park S, Han KS, Kim HK.
Thromb Res. 2011 May;127(5):450-6. Epub 2011 Jan 21.
Link
1179. Vitamin E inhibition on platelet procoagulant activity: involvement of aminophospholipid translocase activity.
Kim JE, Han M, Hanl KS, Kim HK.
Thromb Res. 2011 May;127(5):435-42. Epub 2011 Feb 5.
Link
1178. Thrombomodulin phenotype of a distinct monocyte subtype is an independent prognostic marker for disseminated intravascular coagulation.
Hwang SM, Kim JE, Han KS, Kim HK.
Crit Care. 2011;15(2):R113. Epub 2011 Apr 14.
Link